• National
  • Politics
  • Valley
  • Opinion
  • Money
  • Sports
  • Culture & Lifestyle

  • National
    • Madhesh Province
    • Lumbini Province
    • Bagmati Province
    • National Security
    • Koshi Province
    • Gandaki Province
    • Karnali Province
    • Sudurpaschim Province
  • Politics
  • Valley
    • Kathmandu
    • Lalitpur
    • Bhaktapur
  • Opinion
    • Columns
    • As it is
    • Letters
    • Editorial
    • Cartoon
  • Money
  • Sports
    • Cricket
    • Football
    • International Sports
  • Culture & Lifestyle
    • Arts
    • Brunch with the Post
    • Movies
    • Life & Style
    • Theater
    • Entertainment
    • Books
    • Fashion
  • Health
  • Food
    • Recipes
  • Travel
  • Investigations
  • Climate & Environment
  • World
  • Science & Technology
  • Interviews
  • Visual Stories
  • Crosswords & Sudoku
  • Horoscope
  • Forex
  • Corrections
  • Letters to the Editor
  • Today's ePaper
Tuesday, September 23, 2025

Without Fear or FavourUNWIND IN STYLE

22.12°C Kathmandu
Air Quality in Kathmandu: 52
300+Hazardous
0-50Good
51-100Moderate
101-150Unhealty for Sensitive Groups
151-200Unhealthy
201-300Very Unhealthy
Tue, Sep 23, 2025
22.12°C Kathmandu
Air Quality in Kathmandu: 52
  • What's News :

  • Cabinet expansion
  • Campaign to reassure travellers
  • Pushpa Kamal Dahal
  • Narayanghat-Muglin road
  • Preparations to hold elections

World

Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J Covid shots: study

The study found that CoronaVac received the strongest boost from a viral vector or RNA shot, including against the Delta and Omicron coronavirus variants. Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J Covid shots: study
 Reuters
bookmark
  • facebook
  • twitter
  • Whatsapp
  • mail
Reuters
Published at : January 25, 2022
Updated at : January 25, 2022 13:47

A third booster dose of a Covid-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found.

The study found that CoronaVac received the strongest boost from a viral vector or RNA shot, including against the Delta and Omicron coronavirus variants, researchers from Brazil and Oxford University said on Monday.

China-based Sinovac's vaccine uses an inactivated version of a coronavirus strain that was isolated from a patient in China. It is currently approved in more than 50 countries including Brazil, China, Argentina, South Africa, Oman, Malaysia, Indonesia and Turkey. 

"This study provides important options for policymakers in the many countries where inactivated vaccines ... have been used," said Andrew Pollard, director of the Oxford Vaccine Group and study lead.

However, another study in December found that Sinovac's two-dose shot followed by a booster dose of Pfizer-BioNTech's vaccine showed a lower immune response against the Omicron variant compared with other strains. 

Viral vector vaccines such as the ones developed by AstraZeneca-Oxford and J&J use a weakened version of another virus to deliver genetic instructions for making proteins from the virus against which protection is sought.

Pfizer and BioNTech's mRNA vaccines deliver a genetic transcript with instructions for making viral proteins to teach the body how to defend against infections.

A third dose of CoronaVac also increased antibodies, but the results were better when a different vaccine was used, according to the latest study that included 1,240 volunteers from the Brazilian cities of Sao Paulo and Salvador.

Antibody levels were low before the booster doses, with only 20.4% of adults aged 18-60 and 8.9% of adults aged over 60 having detectable levels of neutralising antibodies. These were seen to significantly increase across every booster vaccine regimen, according to the study, which was published in the Lancet medical journal on Friday.


Related News

World summit to meet on two-state solution as support grows for Palestinian state
North Korea’s Kim says he is open to talks if US drops denuclearisation demand
Four major Western nations recognise Palestinian state, to fury of Israel
Israeli strikes kill 31 people in Gaza City, medics say, as tanks advance
Erdogan says Palestine, US ties and Syria talks on agenda in US trip
Trump says ‘bad things’ will happen if Afghanistan does not return Bagram air base

Most Read from World

Trump to impose $100,000 fee per year for H-1B visas, in likely blow to tech
Sri Lanka resumes key highway project with $500 million new Chinese funding
Boeing, Honeywell sued by Air India crash victim families
Qatar, US nearing defence deal after Israel's attack in Doha, Rubio says
US casts 6th veto at United Nations over war in Gaza

Editor's Picks

How misinformation fuelled panic during Gen Z uprising
At 86, Spanish Carlos Soria sets sights on Manaslu
She made history as first woman chief justice of Nepal. Now as PM
3 Gorkha youths killed in Gen Z protests, leaving families and dreams shattered
Nepal’s immunisation on the brink after vaccine stocks gutted in arsons

E-PAPER | September 23, 2025

  • Read ePaper Online
ABOUT US
  • About the Post
  • Masthead
  • Editorial Standards & Integrity
  • Workplace Harassment Policy
  • Privacy Policy
READ US
  • Home Delivery
  • ePaper
CONTACT US
  • Write for the Post
  • Letters to the Editor
  • Advertise in the Post
  • Work for the Post
  • Send us a tip
INTERACT WITH US
  • Twitter
  • Facebook
  • Instagram
OUR SISTER PUBLICATIONS
  • eKantipur
  • saptahik
  • Nepal
  • Nari
  • Radio Kantipur
  • Kantipur TV
© 2025 www.kathmandupost.com
  • Privacy Policy
Top